On January 21, 2025, China SXT Pharmaceuticals, Inc. announced a securities purchase agreement to sell 14.2 million shares at $0.20 each through a private investment, raising a total of approximately $2.84 million, including debt surrender. The deal also involves warrants allowing purchases at $1.00 per share, which will be adjusted after a reset date.